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Abstract
Background: Annexin A7 is a member of the annexin protein family, which is characterized by its
ability to interact with phospholipids in the presence of Ca2+-ions and which is thought to function
in Ca2+-homeostasis. Results from mutant mice showed altered Ca2+-wave propagation in
astrocytes. As the appearance and distribution of Annexin A7 during brain development has not
been investigated so far, we focused on the distribution of Annexin A7 protein during mouse
embryogenesis in the developing central nervous system and in the adult mouse brain.
Results: Annexin A7 is expressed in cells of the developing brain where a change in its subcellular
localization from cytoplasm to nucleus was observed. In the adult CNS, the subcellular distribution
of Annexin A7 depends on the cell type. By immunohistochemistry analysis Annexin A7 was
detected in the cytosol of undifferentiated cells at embryonic days E5–E8. At E11–E15 the protein
is still present in the cytosol of cells predominantly located in the ventricular germinative zone
surrounding the lateral ventricle. Later on, at embryonic day E16, Annexin A7 in cells of the
intermediate and marginal zone of the neopallium translocates to the nucleus. Neuronal cells of all
areas in the adult brain present Annexin A7 in the nucleus, whereas glial fibrillary acidic protein
(GFAP)-positive astrocytes exhibit both, a cytoplasmic and nuclear staining. The presence of
nuclear Annexin A7 was confirmed by extraction of the nucleoplasm from isolated nuclei obtained
from neuronal and astroglial cell lines.
Conclusion: We have demonstrated a translocation of Annexin A7 to nuclei of cells in early
murine brain development and the presence of Annexin A7 in nuclei of neuronal cells in the adult
animal. The role of Annexin A7 in nuclei of differentiating and mature neuronal cells remains
elusive.
Background
Annexins form a family of structurally related proteins,
which bind to negatively charged phospholipids in a
Ca2+-dependent manner [1]. They are characterized by a
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bipartite structure with a conserved C-terminal core
domain and a unique N-terminal domain that varies in
length and amino acid composition. The C-terminal
domain is formed by either a four- or eightfold repeat of
approximately 70 amino acids, each repeat carrying a
Ca2+-binding site, and is responsible for phospholipid
binding. The N-terminal regions are thought to confer
functional diversity to the annexin proteins [2]. The bio-
chemical features in vitro were analyzed extensively, but
the in vivo functions of annexins remain unclear.
Annexin A7, the first annexin to be described, was isolated
as the agent that mediated aggregation of chromaffin
granules and fusion of membranes and phospholipids in
the presence of Ca2+-ions [3]. Expression studies demon-
strated the distribution of Annexin A7 in a wide variety of
tissues and cells mainly enriched in the cytosol in close
association with membranous structures, but it was also
described in the nucleus of adrenal chromaffin cells [4].
The presence of an alternatively spliced cassette exon gives
rise to two Annexin A7 isoforms corresponding in molec-
ular mass to 47 kDa and 51 kDa. The isoforms differ in
their N-terminal domain and exhibit a tissue-specific
expression pattern. The 47 kDa isoform is present in all
tissues except for skeletal muscle, where the 51 kDa iso-
form is exclusively present. Heart muscle, brain tissue and
red blood cells contain both isoforms [5-8]. Previous
studies indicated that the subcellular localization of
Annexin A7 changes during myoblast differentiation. In
undifferentiated cells the protein is equally distributed
between cytosol and membrane fractions while in differ-
entiated cells it is exclusively present in the membrane
fraction [7]. Reports by Clemen et al. [9] and Herr et al.
[8,10] demonstrated roles for Annexin A7 in shape and
osmotic resistance of red blood cells, platelet aggregation
velocity, and in the velocity of spreading astrocytic Ca2+-
waves. Annexin A7 is also involved in the maintenance of
regular cardiac electrophysiology and Ca2+-homeostasis
[Schrickel et al., submitted]. Detailed reports on appear-
ance and distribution of Annexin A7 during brain devel-
opment are not available. In the present study we focus on
the distribution of Annexin A7 in the developing brain of
mice embryos between E5 and E16, and in the adult
mouse brain.
Results
Annexin A7 is expressed in the early mouse embryo
First we examined the expression of Annexin A7 in ES cells
(Bruce4, established from C57BL/6J mice) and the early
stages of mouse embryonic development at the mRNA
level by northern blot analysis and at the protein level by
Western blotting and immunohistochemistry, respec-
tively. Northern blot analysis shows in ES-cells and at
embryonic days E7, E11, E15, and E17 two mRNA species
of 1.8 kb and 2.4 kb, which result from alternative splicing
in the untranslated 3'end (Fig. 1A) [11]. We found similar
Annexin A7 mRNA levels in the four embryonic stages.
Reprobing with a β -actin probe verified equal loading; the
appearance of a faster migrating mRNA species in addi-
tion to the 2.0 kb species is characteristic for β -actin [12].
On the protein level, ES cells express only the smaller
Annexin A7 isoform of 47 kDa (Fig. 1B, neuro-2a cells and
heart tissue are included for control).
Immunohistochemistry confirmed the presence of the
protein during early development. Annexin A7 immuno-
reactivity using mAb 203–217, which specifically recog-
nizes both isoforms of Annexin A7, can be observed in the
two cell types of the cylinder stage at E5 with a weaker
Annexin A7 expression in the ectoderm (Fig. 2A–C). At E8
Annexin A7 can be detected in almost all tissues of the
embryo (data not shown). A correlation between the pres-
ence of Annexin A7 and the origin of a cell type from one
of the three germ layers is not apparent. We specifically
noted the localization of the protein in the neuroepithe-
lium of the neural fold and tube (Fig. 2D–F, proximal, E8;
Fig. 2G–I, distal, E13). At the subcellular level, Annexin
A7 was present in punctate structures mainly in the
cytosol of all examined cells (Fig. 2E,F). This distribution
was also observed during subsequent development.
Annexin A7 changes its subcellular localization in the 
embryonic brain at E16
Next we analysed the cellular and subcellular distribution
of Annexin A7 in the developing mouse brain (Fig. 3). At
E13–E16 in transverse sections of the embryonic brain,
most of the immunoreactive cells are present in the ven-
tricular germinative zone surrounding the lateral ventricle
(Fig. 3A, overview E16; Fig. 3H, overview E13). A closer
inspection revealed that Annexin A7 is mainly localized in
the cytosol at E13 (Fig. 3B,E). During further development
the immature cells have rounded up two days later, but
they retain Annexin A7 in the cytosol at E15 (Fig. 3C,F). At
E16 we observed the first prominent nuclear staining of
Annexin A7 (Fig. 3D,G) in cells of the intermediate zone
(Fig. 3I, oval), which contains neurons radially migrating
towards the growing neopallium cortex [13,14] and also
glial cells forming the white matter of the adult cortex.
Cells located marginally in the neopallial cortex also
exhibit a nuclear stain. Labelling in the ventricular germi-
native zone is less prominent and the cytosol is no longer
more strongly stained than the nucleus.
Mature neurons in adult mouse brain show an intense 
nuclear staining of Annexin A7
Both Annexin A7 isoforms are found in adult brain tissue
(Fig. 1B). In general, we observed two characteristic stain-
ing patterns for Annexin A7, a prominent nuclear stain in
neurons (determined by lack of GFAP-immunoreactivity,
localization, morphology) and a cytoplasmic and nuclearBMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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stain in astrocytes (GFAP-positive) in all areas of the
mature murine brain. In the neocortex (isocortex)
Annexin A7 was strongly enriched in nuclei of neurons of
all six cortical laminae (Fig. 4A, section derived from cor-
tex temporalis). For control, in the adult brain type-1
astrocytes can be characterized by a positive GFAP-stain
(Fig. 4B). Fig. 4F demonstrates the presence of nuclear
Annexin A7 in a neocortical neuron of the external granu-
lar layer (layer II) and in an astrocytic cell of the neocorti-
cal molecular layer (layer I) which additionally exhibits
an intense signal in the cytoplasm and in cellular
branches. A further cell type of the isocortex showed a
strong immunoreactivity in both, nucleus and cytosol,
and was identified as pyramidal neuron based on mor-
phology and absence of GFAP immunoreactivity. How-
ever, Annexin A7 apparently is more enriched in the
nucleus (Fig. 4E).
In the hippocampal formation we detected prominent
Annexin A7 immunostaining in the stratum pyramidalis
and in the dentate gyrus and also a weak astrocytic stain-
ing (Fig. 4C). The astrocytes are mainly localized in the
area between cells exhibiting nuclear Annexin A7 staining
and show the protein also in the nucleus and the cyto-
plasm (data not shown). When we analyzed the pyrami-
dal neurons in the hippocampus at a higher magnification
we found that Annexin A7 again mainly localized to the
nuclei (Fig. 4G). Polyclonal antibodies gave a similar
staining pattern (data not shown). The intense nuclear
staining was absent in controls either stained only with
the secondary antibody (Fig. 4D) or in brain sections
derived from AnxA7-/- mice stained for Annexin A7 (Fig.
4H). The residual staining seen in the AnxA7-/- brain is
unspecific as it is also present in corresponding negative
controls lacking the primary antibody. The absence of
Annexin A7 protein in brain and other tissues of the
AnxA7-/- mouse has been verified in [10]. In another actual
study of the knock out mouse we detected a thickened
basal membrane and a widened intercellular space. This
may cause unspecific binding of the secondary antibody.
An equal staining of Annexin A7 was also found in the cer-
ebellum (Fig. 5A). Nuclei of neurons in the stratum gran-
ulosum show the most prominent staining (Fig. 5C,D). In
the stratum moleculare, which is poor in cell bodies of
neurons, only a few dots appear which also correspond to
nuclei of neurons. Astrocytes are also positive for Annexin
A7 in the nuclei and cytoplasm (data not shown). The sig-
nal of the pial border and the prominent stain of the white
matter tracts (laminae medullares) are due to Annexin A7
positive astrocytes (Fig. 5 A–C). Higher magnification of
the boundary layer between stratum moleculare and gran-
ulosum (Fig. 5D) revealed an Annexin A7 signal in nuclei,
but also in the cytoplasm and at the plasma membrane of
Purkinje cells (Fig. 5E). The typical pair of dendrites
Expression of Annexin A7 Figure 1
Expression of Annexin A7. (A) Northern blot analysis of 
RNA from ES-cells and embryos E7, E11, E15, E17 probed 
with a full length annexin A7 cDNA. Transcripts of 1.8 and 
2.4 kb are detected in all stages examined (upper panel). Rep-
robing with a β -actin probe verified equal loading (lower 
panel, 2.0 kb band). (B) Murine ES cells (ES) express only the 
small Annexin A7 isoform. Both isoforms are expressed in 
neuroblastoma neuro-2a cells (N2A), heart (HRT) and brain 
tissue (CNS) from adult mice. Proteins from neuro-2a and ES 
cells, heart and brain were resolved by SDS polyacrylamide 
gel electrophoresis (12% acrylamide) and transferred to 
nitrocellulose membranes. The Western blot was probed 
with mAb 203–217 followed by incubation with a peroxidase 
coupled secondary antibody. Detection was with enhanced 
chemiluminescence.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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Annexin A7 immunoreactivity in early mouse embryos Figure 2
Annexin A7 immunoreactivity in early mouse embryos. (A) Phase contrast, embryo E5: The egg cylinder consists of an 
inner cell mass (a) representing the ectoderm and an outer layer of endoderm cells (b). (B) Immunostaining of the paraffin sec-
tion was performed using purified mAb 203–217 and Cy3-conjugated anti-mouse IgG. Annexin A7 is expressed in both cell 
types of the egg cylinder with a strong staining of the endoderm and a weaker staining of the ectoderm. The nuclei are devoid 
of immune reactions. (C) Negative control using the secondary Cy3-antibody only. (D-F) Annexin A7 expression in the prox-
imal neural tube (D) and nearby neural fold (E,F), embryo E8, transverse section. Immunolabeling of Annexin A7 was per-
formed with purified mAb 203–217 and visualization was with an Alexa Fluor 488-conjugated anti-mouse IgG. (D) An intense 
Annexin A7 immunostaining is detectable in the neuroepithelium of the neural tube (a, lumen of neural tube). (E,F) Higher 
magnifications of the neuroepithelium show that Annexin A7 is expressed in the cytosol. Arrowheads point to Annexin A7 
immunoreactivity in the cytosol. (G) Phase contrast, embryo E13, caudal neural tube. (H) Immunostaining of the paraffin sec-
tion was performed using purified mAb 203–217 and Alexa Fluor 488-conjugated anti-mouse IgG. (I) Negative control using 
the secondary Alexa Fluor 488-antibody only. Bar, 20 µm.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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Subcellular localization of Annexin A7 in embryos E13, E15 and E16 Figure 3
Subcellular localization of Annexin A7 in embryos E13, E15 and E16. Paraffin sections of embryonic brain were 
stained with purified mAb 203–217. Annexin A7 was visualized with Alexa Fluor 488-conjugated secondary antibody. (A) 
Overview, at E16 the immature GFAP-negative cells of the forming cerebral neocortex (b) surrounding the lateral ventricle (a) 
are strongly stained; square, a higher magnification of this area is given in (I). (B) Higher magnification of the earlier stage E13 
(H) shows, that the cells are stained in the cytosol (arrowhead). (C) Two days later at E15 the cells have rounded up, and 
Annexin A7 stays in the cytosol. (D) At E16 the first nuclear staining becomes apparent (arrowhead) in cells of the intermedi-
ate zone located between ventricular germinative zone and marginal neopallial cortex as seen in (I), oval. (E-G) Confocal 
microscopy confirms the results in B-D. (H) Overview, at E13 the immature GFAP-negative cells are strongly stained; a, lateral 
ventricle. (I) Higher magnification of a cortical section of (A, square) demonstrating ventricular, intermediate, and marginal 
zones; oval, a higher magnification of this area is given in (D,G).BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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Annexin A7 is present in neurons and astrocytes of the cortex temporalis and hippocampal formation of 10-weeks-old mice Figure 4
Annexin A7 is present in neurons and astrocytes of the cortex temporalis and hippocampal formation of 10-
weeks-old mice. (A) Low magnification of the cortex temporalis presents an Annexin A7 expression in cells of the pial bor-
der, in neurons of all six isocortical laminae, and a weak signal in the adjacent white matter. (B) Corresponding section stained 
with GFAP. (C) Staining in the Stratum pyramidalis (a) and in the dentate gyrus of the hippocampus; square, a higher magnifica-
tion of acorresponding area is given in (G,H). An intense Annexin A7 immunostaining is detectable. (D) Corresponding section 
stained with secondary antibody only. (E) Presence of Annexin A7 in pyramidal neurons (lamina pyramidalis externa) of the 
isocortex temporalis. These neurons were identified based on their morphology, distribution and lack of GFAP staining. 
AnnexinA7 exhibits a punctate staining, which is pronounced in the nucleus (arrowhead). (F) Higher magnification of image (A) 
also shows Annexin A7 in nuclei of neurons (lamina granularis externa (corpuscularis), arrowhead) and in the cytoplasm and 
nuclei of astrocytes (lamina molecularis, arrow; GFAP-confirmed). (G) Higher magnification of the pyramidal neurons in the 
hippocampus confirms the presence of the Annexin A7 protein in the nucleus (arrowhead) of mature neurons. (H) To further 
confirm this, a similar section derived from an AnxA7-/- mouse was stained with the annexin specific antibody and lacked the 
nuclear signal. The residual stain of the tissue is unspecific, as it is also observed in controls of the AnxA7-/- brain omitting the 
primary antibody (data not shown). All paraffin sections were stained with mAb 203–217 (A, C, E, F, G) or anti-GFAP-antibody 
(B). The hippocampal control section (D) lacks the primary antibody.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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points to the margin of the cerebellar cortex. The specifi-
city of the Annexin A7 signal was further confirmed in
similar brain sections of the AnxA7-/- mouse (Fig. 5F). Fig.
5G shows Annexin A7 in neurites (axons) connecting the
laminae medullares with the Purkinje-cell layer. Most
likely these are the axons of the Purkinje-cells. Apart from
these efferent neurites the laminae medullares (lamina
alba, white matter) contain afferent mossy and climbing
fibers. Thus, the intense stain of the cerebellar white mat-
ter arises from Annexin A7 located in astrocytes and
neurites.
Expression of Annexin A7 in the adult human isocortex
In the human parietal neocortex of aged individuals with-
out any neuropathological alterations, subpial astrocytes
exhibited a staining of Annexin A7 in the cytoplasm. A
nuclear presence of Annexin A7 was limited to single
astrocytes (Fig. 6B). Pyramidal neurons, predominantly
those of layer V exhibited Annexin A7 at the plasma mem-
brane of their perikaryon as well as of the apical dendrite
(Fig. 6A,C). The neurons lacked a signal for Annexin A7 in
their nuclei. Apical dendrites within the molecular layer
also indicated a positive staining for Annexin A7 (Fig. 6B).
The staining pattern of Annexin A7 in the human autopsy
brain did not change after pre-treatment with trypsin.
Presence of Annexin A7 in nuclei from neuronal and 
astroglial cells
The nuclear localisation of Annexin A7 in mice observed
in immature cells at E16 and differentiated adult neurons
could be only detected as a strong signal when the brain
sections were pre-treated with trypsin before antibody
staining. This procedure is thought to allow the antibod-
ies to access epitopes masked by the formaldehyde fixa-
tion. Methanol fixation of cultured cells led to
inconsistent results. Antigen retrieval in formalin-fixed
and paraffin-embedded tissue sections employs various
heating or proteolytic pre-treatment methods [[15-17];
Ein Handbuch für die Histologie, dianova GmbH, Ham-
burg, Germany]. These methods can result in moderate or
strong specific antibody staining, but the detectability of
other antigens might be decreased. Moreover, the optimal
pre-treatment has to be individualised for each antigen.
To verify the presence of endogenous Annexin A7 in
nuclei, we used a biochemical approach and purified
nuclei from neuro-2a, PC-12, and C6 cells and treated
them with a hypotonic extraction buffer to obtain the
nucleoplasm (Fig. 7A). The nucleoplasm and the remain-
ing nuclei, from which the nucleoplasm has been
extracted partially, were subjected to SDS-PAGE and West-
ern blotting. Western blots probed with mAb 203–217
showed Annexin A7 in the nucleoplasm of neuronal
(neuro-2a, PC-12) and astroglial (C6) cell lines (Fig. 7A),
however, the large isoform could only be clearly extracted
with nucleoplasm from C6 cells. For control, antibodies
against LAP2α , Emerin and tubulin were used to verify
that the nucleoplasm (marker:LAP2α , which is anon-
membrane-bound isoform of LAP2) was successfully
extracted and also not contaminated by nuclear mem-
branes (marker:Emerin) or by cytoplasm (marker:tubu-
lin). Likewise, in these neuronal and astroglial cell lines
Annexin A7 had been observed in the nucleus by immun-
ofluorescence (Fig. 7B and data not shown). We noticed
no difference between PC-12 and neuro-2a cells, however,
as for the brain sections, we found an increase of the
Annexin A7 staining after pre-treatment with trypsin.
Discussion
In the present study we explored the appearance of
Annexin A7 during mouse development at the mRNA and
protein level and focused on the central nervous system
during embryogenesis. Northern blot and immunohisto-
chemistry analysis show the expression of Annexin A7 in
all embryonic tissues from day E5 on, the earliest day
studied. Differentiating cells, like the neural ectoderm,
which is the origin of the cells belonging to the nervous
system, show Annexin A7 immunoreactivity mainly in the
cytosol. Endodermal as well as mesodermal cells exhibit a
similar subcellular localization of the protein.
In the developing brain we noted a striking change in the
subcellular distribution of Annexin A7. Cells in the stra-
tum germinativum of the neopallial cortex, which sur-
rounds the lateral ventricle, show at E13 and E15 a
staining for Annexin A7 mainly in the cytosol. But this
staining largely disappears and at the following day E16
we detect Annexin A7 in the nucleus of cells in the inter-
mediate and marginal zone of the neopallium. The differ-
ent expression patterns of Annexin A7-positive cells from
the ventricular germinative zone to the marginal zone of
the later neocortex observed in this study are similar to the
developmental patterns of Tenascin-C-positive astroglial
precursors following the guidance of the radial glial cells
[18]. Moreover, the patterns resemble that of migrating
and differentiated neurons described by Berry et al. [13].
Neurons that are generated prenatally in the proliferative
ventricular layer of the neopallial cortex subsequently
migrate through the intermediate zone to form the differ-
ent cortical cell layers in a declining inside-out gradient of
cell maturation. These observations suggested that the
subcellular localization of Annexin A7 depends on devel-
opmental stage and cell type.
In the adult brain we generally observed a nuclear locali-
zation for Annexin A7 in neurons whereas astrocytes
exhibited both a cytosolic as well as a nuclear staining.
However, pyramidal neurons of the isocortex and
Purkinje-cells of the cerebellum exhibited a cytosolic stain
of intermediate intensity including their neurites andBMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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Annexin A7 immunostaining in the cerebellum of adult mice Figure 5
Annexin A7 immunostaining in the cerebellum of adult mice. (A) Low magnification of the cerebellum presents an 
Annexin A7 expression mainly in cells of the stratum granulosum and laminae medullares. (B) Corresponding section stained 
for GFAP. (C) Higher magnification of folia of the cerebellum, where a polyclonal anti-AnnexinA7 antibody was used; square, a 
higher magnification of acorresponding area stained with mAb 203–217 is given in (D). Between stratum granulosum and stra-
tum moleculare the layer of Purkinje-cells (stratum neuronorum piriformium (ganglionare)) can be observed. (D) Staining of 
the band of Purkinje-cells (arrows). The positive Annexin A7-stain in the stratum granulosum is due to staining of the nuclei of 
neurons. (E) In addition to an intense staining of the nucleus, the cell body is AnnexinA7-positive including both dendrites of 
the Purkinje-cell shown. (F) Corresponding section from an AnxA7-/- mouse. (G) AnnexinA7 staining of axons (arrowheads) 
running from the laminae medullares to the Purkinje-cell layer located in the round end of a convolution. Sections A, D, E, F, G 
were stained with mAb 203–217.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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dendrites. We have previously reported the expression of
Annexin A7 in human temporal neocortex and hippocam-
pus obtained from neurosurgery for therapy-refractory
epilepsy and found the two Annexin A7 isoforms
restricted to the cytoplasm and nuclei of astrocytes,
whereas neurons lacked any signal [19]. The hippocampal
area showed typical signs of Ammon's horn sclerosis, but
the adjacent temporal neocortex tissue did not show any
histopathological alterations. This data is in discrepancy
with our actual observation in the murine brain. To deter-
mine if this is due to different methods in immunofluo-
rescence staining or indeed different expression patterns
Annexin A7 immunostaining in human isocortex Figure 6
Annexin A7 immunostaining in human isocortex. (A) Pyramidal neurons (bold arrow) and apical dendrites (small 
arrows) were clearly labeled with the antibody against Annexin A7 in the human parietal cortex. (B) A dendritic staining was 
also seen in the molecular layer (small arrows). In addition the subpial astrocytes were weakly labeled (double headed arrows). 
The staining was cytoplasmic, only few astrocytes showed a nuclear staining as well (inset). (C) Enlargement of (A): Annexin A7 
was seen at the cell membrane of the perikaryon (bold arrow) and the apical dendrite (small arrows). (D) A blank control lack-
ing the primary antibody did not show a specific labeling, but autofluorescent lipofuscin was detectable in the neurons (arrow-
heads). Bar, (A) 70 µm, (B) 50 µm, (B-inset, C) 17 µm, (D) 20 µm.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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in mouse and human, we repeated the
immunofluorescence of human brain. This time we inves-
tigated sections from human parietal cortex of autopsy
brain. The astroglial expression of Annexin A7 could be
confirmed, although not all astrocytes exhibited the
nuclear staining. Pyramidal neurons however indicated a
distinct staining of Annexin A7 most prominent along
their dendrites. The different results obtained for the neu-
rons may be explained by the fact that we previously used
frozen tissue sections or that they were derived from
patients suffering from temporal lobe epilepsia. On the
other hand the actual human brain tissue used was from
aged patients and did not correspond to the age of the
mice included in this study. In cultured cells after cell
damage or apoptosis (unpublished observations) or in
cells treated with a Ca2+-ionophore Annexin A7 translo-
cated from the cytoplasm to cellular membranes [19]. We
therefore favor the hypothesis that Annexin A7 in the sen-
sitive neurons of the human autopsy brain may have sim-
ilarly translocated to the cellular membrane. This property
of translocation and membrane binding is common to all
annexins and commercially available kits for apoptosis
detection employ recombinant AnnexinA5. The presence
of nuclear Annexin A7 in murine brain was confirmed by
Nuclear localization of Annexin A7 Figure 7
Nuclear localization of Annexin A7. (A) Extraction of Annexin A7 from nuclei of neuronal (PC-12, N2A) and an astroglial 
(C6) cell line using a hypotonic buffer. Samples of total cells (c), and corresponding amounts of nuclear membranes (m) and 
nucleoplasm (p) were subjected to SDS-PAGE and Western blotting. Annexin A7 (AnxA7) isoforms are extractable from the 
nucleus of the indicated cells (47 kDa and 51 kDa isoform, arrowhead). For control, immunoblotting of LAP2α  (75 kDa; non-
membrane-bound isoform), Emerin (EM, 34 kDa), and tubulin (TB, 55 kDa) which are specific for nucleoplasm (LAP2α ), 
nuclear membranes (Emerin), and the cytoplasm (tubulin) are shown. Note that the nucleoplasm is only partially extractable. 
(B) Immunofluorescence images of the PC-12 cells used. Cells were fixed with paraformaldehyde, permeabilized with Triton 
X-100, pretreated with trypsin as indicated, and stained with Annexin A7 specific mAb 203–217, DAPI in blue, bar 10 µm.BMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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controls using sections from the AnxA7-/- mouse and by a
biochemical extraction of the protein from the nucleus.
Both Annexin A7 isoforms described in brain tissue seem-
ingly are expressed by neurons and astrocytes, which was
shown using total cell extracts of cultured neuo-2a, PC-12,
and C6 cells. In addition to their expression in brain, both
Annexin A7 isoforms have only been described in heart
muscle and red blood cells [5-8].
Although the inactivation of the annexin A7 gene did not
interfere with the viability and development of knock out
mice [10], their generation allowed us to address the role
of Annexin A7 in specific cell types [8,9]. Indeed, when we
analyzed primary astrocytes from an AnxA7-/- mouse for
Ca2+-dependent signaling processes, we found that they
exhibited a significantly increased velocity of mechani-
cally induced astrocytic Ca2+-waves as compared to wild
type [9]. This led us to propose, that Annexin A7 can act
as a Ca2+-buffer and is involved in Ca2+-homeostasis. In
neurons Ca2+ ions play major roles in various physiologi-
cal and pathophysiological processes [20-25]. One can
speculate about an involvement of Annexin A7 in the reg-
ulation of these Ca2+-dependent processes, propositions
that need further investigation. However, such roles are
confirmed for heart function by studies of Schrickel et al.
[submitted], who described an involvement of Annexin
A7 in the maintenance of a regular cardiac electrophysiol-
ogy and Ca2+-homeostasis.
An altered subcellular location during embryogenesis was
also reported for Annexin A11. The developing gray mat-
ter of the rat embryonic spinal cord exhibited primarily
nuclear localization of Annexin A11, while immunoreac-
tivity was lost from the nuclei in the adult spinal cord
[26]. In contrast, our studies show a relocation of Annexin
A7 from the cytosol to the nucleus in cells of the embry-
onic neuronal tissue. The Annexin A7 distribution is
determined by a variety of factors. An important one
appears to be Ca2+, which promotes binding of Annexin
A7 to membranes and also allows aggregation of annexins
[27]. Binding partners of Annexin A7 such as sorcin might
represent additional factors [28]. Although the members
of the annexin family are generally found at the plasma
membrane, in the cytoplasm or in association with the
cytoskeleton, Annexins A1, A2, A4, A5 and A11 have been
described to be localized at least partially in the nucleus
[26,29,30]. Studies with human foreskin fibroblasts dem-
onstrated that Annexin A1, A4 and A5 are all present in
the nucleus at higher concentration than in the cytosol
[31]. Raising intracellular Ca2+ led to relocation of these
annexins to the nuclear membrane. An important role for
annexins in mediating the Ca2+-signal within the nuclei of
the fibroblasts was proposed. These results mirror studies
with stably transfected C6 cells, in which high intracellu-
lar Ca2+-concentrations induced a marked redistribution
of Annexin A7 from its localization in the nucleoplasm to
the nuclear membrane [19].
None of the annexins contains a typical nuclear localiza-
tion signal and their mechanism of nuclear import
remains to be elucidated. For Annexin A11 it was shown
that nuclear localization is mediated by its N-terminal
region, which also contains a binding side for the S100
protein calcyclin [29]. More recently Tomas and Moss
[32] showed, that Annexin A11 and S100A6 assemble at
the nuclear envelope during nuclear breakdown. Their
role in this process is not known. In general it seems that
the nuclear localization of the annexins is actively regu-
lated. For example the nucleocytoplasmic compartmen-
talization of Annexin A2 is controlled by sequestration of
the AnxA2/p11 complex modulated by phosphorylation
and by a nuclear export signal found in the AnxA2 3–12
region [33]. One function of Annexin A2 in the nucleus,
that appears not to involve binding of p11, has been sug-
gested by its purification as part of a primer recognition
protein complex that enhances DNA polymeraseα -activity
in vitro [34]. The annexins may participate in a nuclear
response to initial cell stimulation or to a Ca2+-transient,
presumably by regulating DNA replication. For Annexin
A7 such a pathway is very speculative at the moment.
Future studies are however directed by these findings and
will concentrate on the identification of the nuclear local-
ization signal of Annexin A7 as well as on the role of
Annexin A7 in the nuclear compartment.
Conclusion
In this article we report the translocation of Annexin A7 to
nuclei of differentiating cells in the developing murine
brain. In the adult brain Annexin A7 generally was
detected in nuclei of neurons. Astrocytes, cerebellar
Purkinje-cells and neocortical pyramidal neurons exhib-
ited both, Annexin A7 in the cytosol and in the nuclei.
Thus, the subcellular localisation of Annexin A7 depends
on the developmental stage and the cell type. A role of
Annexin A7 as well as of other annexins in nuclei remains
speculative. The results obtained by immunofluorescence
were confirmed by extraction of Annexin A7 from nuclei
of neuronal and glial cell lines.
Methods
Animals and tissue preparation
129SV strain mice were used. The day on which the vagi-
nal plug was confirmed was defined as E0. All the animal
experiments were performed in accordance with the
Guide for the Care and Use of Laboratory Animals (NIH
Publication No. 85-23). Pregnant females were sacrificed
by cervical dislocation at various intervals between E5 and
E17. Before E9, embryos were embedded within the
maternal uterus. After E9, embryos were removed from
their membranes and embedded separately. ExperimentsBMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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were performed with four to six animals at each develop-
mental stage. The mature brain used was derived from
mice of three to four month of age. The embryos and tis-
sues were fixed in freshly prepared 4% paraformaldehyde
solution for 2–12 h depending on the tissue thickness
[35]. They were dehydrated with ethanol and embedded
in paraffin according to standard procedures. Microtome
sections were cut at 7–10 µm, placed on slides and stored
until further processing.
Human brain tissue
Five human autopsy brains of male and female patients
without any neuropathological changes (age 61–77 years;
post mortem interval: 12–72 h) were fixed in an aqueous
solution of formaldehyde for three weeks. Blocks of the
parietal neocortex were embedded in paraffin and micro-
tomed at 12 µm thickness. Sections were stained with
aldehydefuchsin Darrow-red to confirm the absence of
neuropathological alterations. All procedures were con-
ducted in accordance with the Declaration of Helsinki and
approved by the ethics committee of the University of
Bonn Medical Center.
Antibodies
Antibodies used in this study were mAb 203–217 directed
against the core domain of mouse Annexin A7 [6] (puri-
fied IgG, 1:50) specifically recognizing both Annexin A7
isoforms [[6,10], and data not shown], a polyclonal anti-
body against mouse Annexin A7 [10] (1:200), a polyclo-
nal antiserum raised against the astrocyte-specific
intermediate filament glial fibrillary acidic protein (GFAP;
DAKO, 1:400), anti-β -tubulin (Sigma, 1:1000), anti-
Emerin (novocastra, 1:2000), and polyclonal anti-LAP2α
(kindly provided by Ronald Foisner, 1:5000).
Immunofluorescence microscopy
Immunohistochemical staining using mAb 203–217 as
the primary antibody was with AlexaFluor488-conjugated
goat anti-mouse IgG (Molecular Probes, Leiden, The
Nether-lands) or Cy3-labeled goat anti-mouse IgG as the
secondary antibodies. Polyclonal anti-Annexin A7 anti-
body and anti-GFAP-antibody were combined with Alexa
Fluor 568-conjugated goat anti-rabbit IgG (Molecular
Probes). The specific labelling of Annexin A7 detected
with the anti-mouse-IgG secondary antibodies in mouse
tissue sections was confirmed using primary antibodies,
which were directly coupled to Alexa Fluor488.
The paraffin-embedded sections were first treated three
times for 2 min in xylene to remove paraffin and then
rehydrated step by step with descending concentrations of
ethanol for antibody staining [35]. After three washings in
PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5
mM KH2PO4, pH 7.4), the tissue sections were incubated
in PBS containing 0.1% trypsin for 10 min at room tem-
perature to free formaldehyde-crosslinked epitopes [15-
17]. After additional three washes with PBS, non-specific
binding sites were blocked by incubating the slides with
PBG (0.5 % BSA, 0.045 % fish gelatine in PBS) in 10%
normal goat serum (NGS) for 2 h. Incubation with the pri-
mary antibodies was performed at 4°C overnight diluted
in PBG supplemented with 1 % NGS. After five washes in
PBG for 5 min each, the slides were incubated for 1 h with
the secondary antibody at room temperature, washed
three times in PBG and three times in PBS, 5 min each,
rinsed in water and embedded in gelvatol [36]. For con-
trol, sections were incubated only with the secondary anti-
body or sections obtained from an annexin A7 knockout
mouse were used [10]. Samples were examined with a
confocal laser scan microscope (Leica TCS SP; Leica, Ben-
sheim, FRG).
Immunofluorescence microscopy of human brain
The paraffin-embedded human brain sections were depar-
affinzed likewise. Immunostaining for Annexin A7 was
performed using the monoclonal antibody mAb 203–
217. Microwave pre-treatment was used for all sections
[15]. Trypsin pre-treatment was used as indicated. Carbo-
cyanine 2 and 3 labeled anti-mouse IgG secondary anti-
bodies (Dianova, Hamburg, Germany) were used to
detect the primary antibody and showed similar staining
patterns. Blank controls were performed, too.
Cell culture and growth conditions
The cell lines used were cultured according to the instruc-
tions provided by ATCC: murine neuroblastoma neuro-2a
(ATCC CCL-131), rat pheochromocytoma PC-12 (ATCC
CRL-1721), and rat glioblastoma C6 (ATCC CCL-107).
One day before fixation with 4%paraformaldehyde and
permeabilization with 0.5% Triton X-100, cells were
seeded on coverslips. Immunostaining was performed as
described for the tissue sections with or without the
trypsin treatment.
Extraction of nuclear Annexin A7
Cultured cells were trypsinized, counted and washed once
in PBS. They were resuspended in buffer1 (0.32 M
sucrose, 10 mM Tris, pH8.0, 3 mM CaCl2, 2 mM Mg-ace-
tate, 0.1 mM EDTA, 0.5% NP40, 1 mM DTT, 0.5 mM
PMSF; 1 × 107cells/400µl buffer) and sonified on ice (son-
ifier UP200S, dr.hielscher, 40 s, amplitude 50%, cycle
0.5). This step was repeated until no more intact cells were
observed by light microscopy. The resulting homogenate
was centrifuged at 500 g for 5 minutes, washed twice in 1
ml buffer 1 without NP40 and centrifuged again. The
resulting pellet contains purified nuclei. For partial
extraction of the nucleoplasm according to [37], nuclei
were resuspended in buffer 2 (20 mM Hepes, pH 7.9, 1.5
mM MgCl2, 20 mM KCl, 0.2 mM EDTA, 25%v/v glycerine,
0.5 mM DTT, 0.5 mM PMSF; nuclei of 107cells/30  µlBMC Neuroscience 2005, 6:25 http://www.biomedcentral.com/1471-2202/6/25
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buffer) and incubated on ice for 30 minutes. An equal vol-
ume of buffer 3 was added in aliquots (20 mM Hepes, pH
7.9, 1.5 mM MgCl2, 800 mM KCl, 0.2 mM EDTA, 25%v/v
glycerine, 0.5 mM DTT, 0.5 mM PMSF, 1% NP40, pro-
tease inhibitor cocktail (Sigma)) and the solution was
incubated while shaking for further 30 minutes on ice.
Then the solution was centrifuged for 15 minutes at
14.000 g, the resulting supernatant was used as nucleo-
plasm, and the pellet was washed once and adjusted to an
equal volume with PBS. Nucleoplasm and nuclear pellet
were subjected to SDS-PAGE and Western blotting.
Western blotting
Cells or cellular fractions were lysed in SDS sample buffer
and homogenates were subjected to SDS-PAGE. Western
blotting was carried out using the method of Towbin et al.
[38]. Peroxidase-coupled secondary antibodies (Sigma)
and the supersignal enhanced chemiluminescence system
(Pierce, Rockford, IL, USA) were used.
Embryo Multiple Tissue Northern Blot
The presence of Annexin A7 mRNA in mouse ES cells and
embryos E7, E11, E15 and E17 was analyzed by northern
blot analysis. An Embryo Multiple Tissue Northern Blot
membrane was obtained from Clontech Laboratories
(Heidelberg, FRG). It contained approximately 2 µg of
poly(A)+ RNA per lane from four different stages of mouse
development. RNA from ES cells was isolated with the
RNeasy kit (Qiagen). The membranes were hybridized
with a random-primed [α -32P]-dATP-labelled full length
annexin A7 cDNA probe and with a β -actin specific probe
for control in ExpressHyb solution according to the man-
ufacturer's directions.
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